The increased accessibility of cannabis and cannabinoids has created challenges for clinicians treating cancer patients, as many patients are turning to these products for symptom relief or cancer treatment without sufficient evidence. An ASCO guideline provides recommendations for the medical use of cannabis and cannabinoids in adults with cancer. The lack of scientific evidence is attributed to federal regulations and clinician hesitancy to discuss cannabis. Key recommendations include improving communication with patients, educating clinicians, and prioritizing research in this area. It is emphasized that there is no high-quality evidence to support the use of cannabis or cannabinoids for treating cancer.
Source link
ASCO guideline helps clinicians address cannabis use ‘head on’ with their patients
